Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Okuno, John M. Kane, Margaret Von Mehren, Burton L. Eisenberg

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2420
Number of pages1
JournalAnnals of surgical oncology
Issue number7
StatePublished - Jul 2012

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this